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Abstract
Background: Serum ascites albumin gradient (SAAG) has been recognized as a reliable marker in the differential
diagnosis of ascites. The etiological background of cirrhosis is rather different between western countries and
eastern countries. The threshold of SAAG in Chinese ascitic patients has not been evaluated yet. The aim of this
study was to define a new reasonable threshold of SAAG in Chinese ascitic patients.
Methods: Adult patients with ascites admitted to the Shanghai Changzheng Hospital from Jan 2004 to Jun 2010
were retrospectively analyzed. The diagnostic criteria for cirrhotic ascites are clinical manifestations, radiological
features and esophageal-gastric varicosis, or histopathology. Serum was detected by chemical method using a
commercial kit. We used receiver operating characteristic (ROC) analysis to achieve maximal sensitivity and
specificity of SAAG.
Results: The mean value of SAAG in portal-hypertension-related ascites was significantly higher than that in the
non-portal-hypertension-related ascites (21.15 ± 4.38 g/L vs 7.48 ± 3.64 g/L, P = 0.002). The SAAG cut-off value under
12.50 g/L predicted portal hypertension ascites with the sensitivity of 99.20%, specificity of 95.10% and accuracy of
97.65%.
Conclusions: SAAG is useful to distinguish portal-hypertension-related ascites and non-portal-hypertension-related
ascites, and 12.50 g/L might present as a more reasonable threshold in Chinese ascitic patients.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
1602582638991860.
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Introduction
Ascites is a common manifestation of advanced liver
disease. Besides, it can also occur in individuals with ex-
trahepatic diseases such as abdominal malignancy, tuber-
culosis, and autoimmune diseases. Traditionally, ascites is
classified as being either transudative or exudative based
on the ascitic fluid total protein (AFTP) concentration [1],
the ratio of ascitic fluid protein concentration to serum
total protein concentration or lactic dehydrogenase (LDH)
[2]. However, the serum ascites albumin gradient (SAAG),
defined as the serum albumin concentration minus the
ascitic fluid albumin concentration, has been proposed as
a physiologically based alternative in the classification of
ascites in the past 20 years [3-5]. Hoefs [6] first introduces
the SAAG and reports that SAAG can reflect the portal
vein pressure and improve the accuracy of ascites identifi-
cation. Thereafter, several investigators also demonstrate
that the superiority of SAAG in distinguishing portal hyper-
tensive ascites (SAAG> 11 g/L) and non-portal hypertensive
ascites (SAAG< 11 g/L) [6-9]. Thus, SAAG 11 g/L has been
considered as a reasonable threshold in clinical practice.
However, there are also some controversies for SAAG
[10-12]. In 2002, Goran et al. [13] revise the threshold of
SAAG and find that when using the cut-off value of 11 g/L,
the diagnostic sensitivity is 97.56% and specificity is 46.34%,
while using 15.86 g/L, the sensitivity and specificity could
reach the maximum. According to Starling, SAAG is the
best indicator of portal hypertension to distinguish non-
portal hypertensive and portal hypertensive ascites [14].
However, the best threshold may call further research, the
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primary study reporting 11 g/L only included the ascites
due to cirrhosis and tumor, except tuberculosis. In fact,
tuberculous ascites are also frequently seen in clinical
practice. Cirrhosis is mainly caused by alcohol abuse in
Western countries, while in China by Hepatitis B virus
infection. Besides, China is also an epidemic area for
tuberculosis. To date, the SAAG in Chinese patients with
ascites has not been evaluated yet. Hence, this study
aimed to define a new cut-off value of SAAG with
maximal sensitivity and specificity in Chinese patients
with ascites.
Material and methods
Patients
Adult patients with ascites admitted to the Shanghai
Changzheng Hospital from Jan 2004 to Jun 2010 were
retrospectively analyzed. The diagnostic criteria for cir-
rhotic ascites are mainly based on clinical manifestations,
radiological features and esophageal-gastric varicosis, or
histopathology, excluding spontaneous bacterial periton-
itis (SBP), malignancy and tuberculosis. Malignant ascites
was diagnosed when the results of ascitic fluid cytologic
study or peritoneal biopsy was positive. The diagnosis of
tuberculous peritonitis required ascitic acid-fast stain or
mycobacterial growth in a culture of ascites or peritoneal
biopsy with or without histologically proven granuloma-
tous peritonitis, and without tuberculous pericarditis.
Serum and ascites fluid were obtained (maximum interval
24 hours) and were tested for albumin concentration and
other related parameters, the albumin concentration was
detected by chemical method using a commercial kit
(P800, Roche), other parameters included ascite routine,
protein, tumor marker, cast-off cells, ADA. The patients
with unknown origin of ascites or without data of SAAG
were excluded. We used cirrhotic ascites as Portal-
hypertension-related (PHT) ascites, and malignant or tu-
berculous ascites as Non-portal-hypertension-related
(NON-PHT) ascites.
Statistical analysis
Continuous variables were tested for normal distribution
and expressed as mean ± standard deviation (SD) and
analyzed by Student’s t test. Rates were analyzed by Chi-
square test. ROC curve was used to assess the diagnostic
value of SAAG. The statistical analysis was performed
using SPSS 17.0 (SPSS Inc., Chicago, IL, USA) and P < 0.05
was considered statistically significant.
Results
Patient characteristics
A total of 213 patients diagnosed with ascites were
included in this study. The baseline characteristic is
shown in (Table 1). The clinical findings of the patients
with PTH group and NON-PTH group were similar
with respect to age and sex ratio.
SAAG analysis
The mean SAAG level of all patients involved was 15.95 ±
7.82 g/L. The mean level of SAAG in the PHT group
(cirrhotic ascites) was significantly higher than that in the
NON-PHT group (malignant and tuberculous ascites)
(21.15 ± 4.38 g/L vs 7.48 ± 3.64 g/L, P = 0.002). Besides,
the SAAG levels of the patients with malignant or tuber-
culous ascites were both significantly lower than that of
patients with cirrhotic ascites (Table 2). In the PHT group,
all patients had a SAAG of 11 g/L or greater. While in the
NON-PHT group, 12 patients had a SAAG of 11 g/L or
higher, and 69 patients had a SAAG less than 11 g/L
(Figure 1).
ROC curve
The ROC curve of SAAG is shown in Figure 2 (Figure 2).
The area under the curve was 0.987, and the SAAG cut-
Table 1 Baseline characteristics of the patients with
ascites
Male : female 116:97
Mean age(y) 56.82 ± 14.69
Cirrhoticascites 132
HepatitisB 82
HepatitisC 1
Schistosomiasis 5
Alcoholic cirrhosis 15
Primary biliary cirrhosis 12
Cryptogeniccirrhosis 17
NON-PHT ascites 81
Malignantascites 54
Gastrointestinal cancer 28
Pancreatobiliary cancer 12
Gynecological cancer 5
Other cancers* 4
Unknown origin# 5
Tuberculous ascites 27
* Hepatocellular cancer excluded.
# The unknown origin herein means the ascites were caused by malignant
tumor, while we failed to determine the primary site of the tumor after
routine examination.
Table 2 SAAG levels of the patients with ascites
Cause of ascites SAAG (g/L)
Cirrhotic ascites 21.15 ± 4.38
Malignant ascites 8.48 ± 3.68*
Tuberculous ascites 5.48 ± 2.64*
*P<0.05, compared with cirrhotic ascites.
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off value 12.50 g/L was the best threshold to predict
PHT ascites with a sensitivity of 99.20%, a specificity of
95.10% and an accuracy of 97.65%. When using the
SAAG cut-off value 11 g/L, its sensitivity and specificity
were 100.00% and 85.19% with an accuracy of 94.37%.
The accuracy and specificity using SAAG 12.50 g/L were
significantly higher than those using SAAG 11 g/L
(accuracy, 97.65% vs 94.37%,P<0.01; specificity, 95.10%
vs 85.19%, P<0.01).
Discussion
Starling [14] recognizes that the protein content of
edema fluid is a reflection of its osmotic pressure and
that the osmotic pressure gradient between blood and
interstitial fluid is a direct function of the corresponding
capillary hydrostatic pressure gradient. According to his
concept, the protein concentration gradient between
serum and ascites reflects the portal pressure. Hoefs [6]
first reports a liner correlation between the SAAG and
portal venous pressure in 56 patients with chronic liver
disease. More recently, this relationship is also con-
firmed by Rector and Reynolds [8], who report an excel-
lent correlation between the SAAG and portal pressure.
Using AFTP to distinguish exudate and transudate is
influenced by serum protein concentration as well as
portal pressure. In contrast, the SAAG correlates directly
with only one physiologic factor, the portal pressure [6].
Portal pressure keeps stable, and therefore there is no or
only minor change of SAAG despite diuresis or therapeutic
paracentesis. Hence, it is possible to understand why the
SAAG 11 g/L has been widely used to differentiate PHT
Figure 1 The scatter of SAAG in classifying samples. In the PHT group, all patients had a SAAG of 11 g/L or greater. While in the NON-PHT
group, 12 patients had a SAAG of 11 g/L or higher, and 69 patients had a SAAG less than 11 g/L.
Figure 2 The ROC curve of SAAG. The area under the curve was
0.987, and the SAAG cut-off value 12.50 g/L was the best threshold
to predict PHT ascites with a sensitivity of 99.20%, a specificity of
95.10% and an accuracy of 97.65%. The accuracy and specificity
using SAAG 12.50 g/L were significantly higher than those using
SAAG 11 g/L (accuracy, 97.65% vs 94.37%,P<0.01; specificity, 95.10%
vs 85.19%, P<0.01).
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and NON-PHT ascites. However, Kajani et al. [15] report
that when using the value of SAAG 11 g/L for differen-
tiating PHT and NON-PHT ascites, the accuracy is only
87.5%. In addition, SAAG corrected with serum globulin
level could also promote the accuracy to determine portal
hypertension [16].
Cirrhosis, cancer and tuberculosis are the most com-
mon causes of ascites. As mentioned above, most studies
about SAAG are performed in patients with cirrhotic or
malignant ascites. However, its utility in tuberculous
ascites has not been assessed yet. Therefore, our study
involved 27 patients with tuberculous ascites. In this
analysis, all the patients with cirrhotic ascites had SAAG
of 11 g/L or greater, which was rather similar to the
study by Shakil et al. [17]. In contrast to the study by
Kajani et al. [15], the causes of cirrhosis did not appear
to affect SAAG. The albumin gradient in 83 patients
with viral-hepatitis-related cirrhosis (21.28 ± 4.22 g/L)
was very near to that in the 49 patients with non-viral-
hepatitis-related cirrhosis (20.94 ± 4.67 g/L). In addition,
the SAAG in 117 patients with nonalcoholic liver disease
was not different from that in the 15 patients with alco-
holic liver disease (21.26 ± 4.41 g/L vs 20.27 ± 4.17 g/L).
With regard to the discrimination between malignant
and nonmalignant ascites, Pare et al. [7] report that
SAAG less than 11 g/L is an excellent criterion for the
diagnosis of malignant origin of ascites. Similar observa-
tions have also been made by Mauer et al. [5]. Based on
the present experience, it appears that the criterion of
SAAG less than 11 g/L for the distinction between ma-
lignant and nonmalignant ascites may be less specific
than previously thought. In the present study, a SAAG
less than 11 g/L was seen in only 43 of 54 patients with
malignant ascites without metastatic liver involvement.
Similarly, the gradient in the patients with malignant
ascites also did not differ from the gradient in the
patients with tuberculous ascites. It suggests that SAAG
cannot further distinguish malignant ascites from tuber-
culous ascites.
Runyon et al. [9] report a very high accuracy of 96.7%
for SAAG of 11 g/L based on 901 samples. In our study,
when using SAAG 11 g/L, its accuracy was 94.37%,
which was slightly lower than 96.7%, while the specificity
was only 85.19%. This may be due to the different ascitic
etiology between western and eastern countries. The
threshold 11 g/L is based mainly on the prevalence of
alcoholic cirrhosis in Western countries. In China, cir-
rhosis is mostly caused by HBV infection. Furthermore,
the previous evaluation of diagnostic tests often uses
sensitivity, specificity and accuracy, which often depend
on the prevalence of study population. In fact, the ascitic
prevalence is different in western and eastern countries.
Moreover, the receiver operating characteristic (ROC)
curve is currently recognized as the best way to measure
the diagnostic information and decision-making. The
cut-off value obtained by ROC curve has greater accur-
acy and clinical utility [18,19]. Our research achieved a
new value of SAAG of 12.5 g/L by ROC curve. Com-
pared with the previous SAAG of 11 g/L, the new SAAG
had higher accuracy and specificity to distinguish PHT
and NON-PHT ascites.
Based upon the data herein presented, we conclude
that SAAG is useful to distinguish PHT and NON-PHT
ascites, and 12.5 g/L might present as a more reasonable
threshold in Chinese ascitic patients. However, further
study is still needed to be done using larger samples.
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